Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
‘Safer use of intravenous gentamicin for neonates’ how-to guide Why do we need an alert? • Used in 89 per cent of neonatal units • Over 500 patient safety incidents reported to NPSA in 2008/2009 • Side effects include vestibular and auditory damage, and nephrotoxicity • Narrow therapeutic range necessitates regular monitoring of blood serum concentrations Gentamicin pharmokinetic information Gentamicin is a broad spectrum aminoglycoside antibiotic which is widely used in the treatment of neonatal infection. It is not absorbed intestinally and therefore is given by injection. It is associated with a risk of kidney damage and hearing impairment. Adverse effects are particularly associated with patients with poor renal function and where higher gentamicin blood levels and longer duration of therapy have been used. Neonatal Nurses Association 5 units nationally piloting 6 additional units as controls 8 weeks of data PSA NPSA’s RLS RCA of incidents National survey Literature review Expert working group PILOT COLLABORATION EVIDENCE Background to alert development What does the alert say? Local protocol Use care bundle PDSA cycle Measurement Training • A local gentamicin protocol must be available • Use the four elements of the care bundle • Use small cycles of change with a sample of patients • Measure care bundle compliance daily • All relevant staff should be provided with applicable training Develop a local gentamicin protocol Local protocol Use care bundle PDSA cycle Measurement Training • A local protocol is available that clarifies: • The initial dose and frequency of administration • Blood level monitoring requirements • Arrangements for subsequent dosing adjustments based on blood levels taken Ensure local policies include bundle Local protocol Use care bundle PDSA cycle Measurement Training 24-hour clock •24-hour clock format should be used when prescribing •Unused time slots in prescription administration record should be blocked out at time of dosing to prevent wrong time dosing Coloured apron •Interruptions during the preparation and administration of gentamicin should be minimised by the wearing of a disposable coloured apron by staff to indicate that they should not be disturbed Doublechecking •A doublechecking prompt should be used during the preparation and administration of gentamicin Dose within one hour •The prescribed dose of gentamicin should be given within one hour of the prescribed time Double checking prompt Local protocol Use care bundle PDSA cycle Measurement Training PDSA cycle applied to gentamicin Local protocol Use care bundle •Share your results with your staff and senior leaders •Implement identified actions arising from your data analysis •Do we understand the measures we are using? •Who will analyse the data? •How often will data be analysed? Act Plan Study Do PDSA cycle Measurement Training •Analyse the data at monthly data review meetings •What elements of the care bundle need addressing? •Ensure compliance charts, audit charts and doublechecking prompts are all available •Collect data Add more patients after each cycle Local protocol Use care bundle PDSA cycle Measurement Training • Start the actions in the alert for one patient and move through the PDSA cycle • When your run chart shows at least 80 per cent compliance add more patients and start the cycle again • This process should be repeated from one patient, to three, to five, etc. (this is the 1:3:5 approach) Three steps to measurement Local protocol Fill out compliance chart (appendix A) after each administration of gentamicin Use care bundle PDSA cycle Use above compliance charts to populate audit charts (appendix B) Measurement Training Use above weekly audit charts to populate extranet on a monthly basis Complete the compliance chart Local protocol Use care bundle PDSA cycle Care bundle compliance chart Care bundle daily audit chart Measurement Training Extranet / run chart 243 128 4627 01/01/2010 16.07 Complete the compliance chart Local protocol Use care bundle PDSA cycle Care bundle compliance chart Care bundle daily audit chart Measurement Training Extranet / run chart Fill out the audit chart and totals Local protocol Use care bundle PDSA cycle Care bundle compliance chart Care bundle daily audit chart Measurement Training Extranet / run chart Upload audit totals on the extranet Local protocol Use care bundle PDSA cycle Care bundle compliance chart Care bundle daily audit chart Measurement Training Extranet / run chart From the daily audit chart Upload audit totals on the extranet Local protocol Use care bundle PDSA cycle Care bundle compliance chart Care bundle daily audit chart Measurement Training Extranet / run chart Helpful resources Local protocol Use care bundle PDSA cycle Measurement Training • In addition to these slides you can also expect the following resources to aid in your implementation: • Instructional Webinar presentations • FAQs published on the website • Resources on PDSA cycles and measurement from the Patient Safety First and 1000 Lives campaign websites Therapeutic drug monitoring: why do it? • Prevent drug toxicity • Ensure drug efficacy Principles of therapeutic drug monitoring Understand what you are measuring pre-dose trough concentration post-dose peak concentration checking efficacy and/or clearance Check when you should be taking levels Interpret the results leave the dose as is adjust the dose and/or the dosing interval question if you need to resample and, if so, when Communicate and document your actions and escalate any concerns if necessary Be sure to follow your local gentamicin policy when progressing through the above principles Support with the measurement extranet • Patient Safety First Office: 020 79279569 or www.patientsafetyfirst.nhs.uk • 1000 Lives Office (Wales): 029 20827651 or www.1000livescampaign.wales.nhs.uk or the 1000 Lives Campaign contact for the Health Board Queries about the alert • Please email [email protected] or call 020 79279514